Aramis Biosciences, Inc.

Quick facts

Phase 2 pipeline

• A197 Ophthalmic Solution · Ophthalmology
  A197 Ophthalmic Solution is a topical corticosteroid used to reduce inflammation in the eye.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aramis Biosciences, Inc. portfolio CI brief
• Aramis Biosciences, Inc. pipeline updates RSS